Trials / Active Not Recruiting
Active Not RecruitingNCT05079984
Agile Development of a Digital Exposure Treatment for Youth With Chronic Musculoskeletal Pain
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 35 (estimated)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 10 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
This project proposes to systematically develop and evaluate the feasibility and preliminary effectiveness of a digitally delivered, graded exposure treatment for youth with chronic musculoskeletal pain, utilizing a sequential replicated and randomized single-case experimental design (SCED). SCED provides the opportunity to rigorously evaluate treatment effectiveness at the individual level. Development of iGET Living will be based on a series of short iterations, with alpha testing (Aim 1) on a small sample of adolescents with chronic pain (N = 15). For Aim 1, participants will participate in three, two hour focus groups (one per week over the course of three weeks), resulting in 6 total hours of participation per participant for Aim 1. Aim 2 will involve a sample (N = 20 youth) of naïve end-users. Participants will be enrolled in a baseline period ranging from 7-25 days (done to support SCED methodology) after which they will be enrolled in the online intervention program, lasting 6-weeks. Patients will be contacted 3-months post-discharge from treatment (week 22 of enrollment) and will complete self-report outcome measures at this time.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Graded exposure treatment (GET) | Graded-exposure is a theory driven, individually tailored, and evidenced based behavioral intervention for individuals with chronic pain targeting pain-related impairment by exposing patients to previously feared and avoided activities. |
Timeline
- Start date
- 2022-05-02
- Primary completion
- 2025-05-13
- Completion
- 2025-10-01
- First posted
- 2021-10-15
- Last updated
- 2025-06-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05079984. Inclusion in this directory is not an endorsement.